Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
- PMID: 33192990
- PMCID: PMC7606850
- DOI: 10.3389/fneur.2020.557233
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Erratum in
-
Corrigendum: Middle Meningeal Artery Embolization for Chronic Subdural Hematoma.Front Neurol. 2021 Mar 22;12:666701. doi: 10.3389/fneur.2021.666701. eCollection 2021. Front Neurol. 2021. PMID: 33828525 Free PMC article.
Abstract
Chronic subdural hematoma (cSDH) is a common disease process associated with significant morbidity that occurs most often in elderly patients. Asymptomatic patients are typically treated conservatively, with surgical intervention reserved for patients with symptomatic and/or large hematomas that cause brain compression. However, conservatively managed cSDH cases frequently progress, and surgical evacuation of cSDH is associated with high rates of complication and recurrence. Recently, successful treatment of cSDH via middle meningeal artery (MMA) embolization has been reported in small case series and case reports. This article reviews the existing literature on MMA embolization for cSDH and discusses the need for randomized control trials and/or large prospective studies to establish the efficacy of MMA embolization for this disease.
Keywords: MMA embolization; cSDH; chronic subdural hematoma; endovascular cSDH treatment; middle meningeal artery embolization.
Copyright © 2020 Catapano, Nguyen, Wakim, Albuquerque and Ducruet.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources